logo
Custom Glass Solutions Establishes Upper Sandusky as New Corporate HQ

Custom Glass Solutions Establishes Upper Sandusky as New Corporate HQ

Business Wire09-05-2025

UPPER SANDUSKY, Ohio--(BUSINESS WIRE)-- Custom Glass Solutions (CGS), a proud American manufacturer of engineered glass solutions and portfolio company of Stellex Capital Management, is pleased to announce that Upper Sandusky, OH, is now the official corporate headquarters for all CGS operations nationwide.
The recent tariff policies have created a favorable environment for domestic manufacturers. Macroeconomic tailwinds combined with our commitment to innovation and service are propelling our business forward.
This move marks a significant step forward for CGS as the company ramps up production to meet a surge in demand, driven in part by customers seeking to onshore their supply chains. To support the growth opportunities, the Upper Sandusky facility is adding at least 30 new manufacturing jobs and actively seeking motivated individuals to join the team.
'Choosing Upper Sandusky as our corporate headquarters was a natural decision,' said Matt Dietrich, CEO of CGS. 'We've been a part of this community since 1974 so our roots are here. As we continue to grow, invest in our people and lead through innovation, it just makes sense that Upper Sandusky should be the center of our operations.'
In addition to the ramp-up in Upper Sandusky, CGS is expanding in Fostoria, OH, where 70 new jobs have been added to support a facility expansion and new capital equipment that adds automation, throughput and capacity. And at its Broken Arrow, OK, facility, CGS is investing in new capabilities to further enhance its product portfolio. This growth comes alongside the strategic consolidation of operations in Trumbauersville, PA, and CGS's previous headquarters in Worthington, OH.
'We have realigned our footprint to drive efficiencies and focus,' said Dietrich. 'In turn, we are reinvesting in our operations and focusing our resources to support our growth goals.'
CGS has seen an increase in demand from current and prospective customers looking to secure their supply chains with U.S.-based suppliers. 'The recent tariff policies have created a favorable environment for domestic manufacturers,' Dietrich said. 'Macroeconomic tailwinds combined with our commitment to innovation and service are propelling our business forward.'
The company is also developing into a leader in bullet- and blast-resistant glass technologies with its Optishield™ line of transparent armor products. Optishield Tactical is designed to provide invisible, level NIJ3A ballistic protection for windshields and side glass in Law Enforcement vehicles. Together with Dana Safety Supply, CGS's exclusive distributor and installer of Optishield Tactical, the companies are setting the standard for vehicle armoring solutions. In addition to law enforcement applications, CGS is also deploying Optishield in a first-of-its-kind, fully-ballistic bus barrier dubbed Transit Assault Barrier that protects transit operators from the ever-increasing risk of assault.
To meet the influx of demand, CGS is actively recruiting and hiring with open positions posted at www.workatcgs.com. Offering a range of shifts, competitive benefits and a culture rooted in internal promotion, CGS provides career opportunities for entrepreneurial, hard-working individuals. New employees may look forward to wage increases at 90 and 180 days as well as an improved and comprehensive benefits package.
The Fostoria team will host a ribbon-cutting event in June for employees and the community to see the growth and new technology firsthand.
'Our future is built on the talent and passion of our people,' Dietrich said. 'We're offering more than just a job — we're building careers with purpose, growth and impact.'
About Custom Glass Solutions
Custom Glass Solutions, LLC is North America's leading producer of large-format, laminated glass systems. In addition to laminated glass, CGS also manufactures flat, bent, and tempered glass systems, offering a broad range of capabilities and the most diverse selection of products for many different transportation and mobile equipment segments. Through its Network business, CGS also works with insurance companies, fleet operators and OEM customers to coordinate glass replacement services. Today, the company operates two facilities in Ohio and one in Oklahoma and employs 600 hundred dedicated employees serving customers across the North American market.
About Stellex Capital Management
With offices in New York, Detroit, Pittsburgh and London, Stellex Capital is a private equity firm with $5 billion in AUM. Stellex seeks to identify and deploy capital in opportunities that stand to benefit from its operationally focused and hands-on approach to investing. Portfolio companies are supported by Stellex's industry knowledge, operating capabilities, network of senior executives, strategic insight, and access to capital. Sectors of particular focus include aerospace, defense & government services, transportation & logistics, manufacturing, real economy & business services, food processing and tech-enabled services. Additional information may be found at www.stellexcapital.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Simulations Plus Releases ADMET Predictor® 13
Simulations Plus Releases ADMET Predictor® 13

Yahoo

time28 minutes ago

  • Yahoo

Simulations Plus Releases ADMET Predictor® 13

Expanded functionality and advanced AI/ML capabilities deliver faster, more accurate predictions and streamline enterprise deployment RESEARCH TRIANGLE PARK, N.C., June 05, 2025--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the release of ADMET Predictor® 13, its flagship machine learning (ML) modeling platform for the design, optimization, and selection of new molecules during various stages of drug discovery. ADMET Predictor 13 features advancements in three main areas: First-to-invent advantage: clients can harness enhanced high-throughput PBPK (HT-PBPK) simulations—powered by GastroPlus®—combined with the upgraded AI-driven drug design (AIDD) engine to enable faster, smarter decision-making at the intersection of chemistry and pharmacokinetics. Elevated predictive power: ADMET Predictor 13 offers an expanded suite of next-gen ADMET models, built with updated AI science and premium datasets, which boost accuracy across key endpoints and reinforce scientific rigor and validation. Enterprise-ready automation: with extended APIs, Python scripting support, and IT-friendly deployment capabilities, ADMET Predictor 13 delivers the automation and scalability required by today's data-centric R&D teams. "ADMET Predictor has long been the standard for discovery modeling platforms in the pharmaceutical space," said David Miller, Vice President of Cheminformatics of Simulations Plus. "Before artificial intelligence and machine learning became industry buzzwords, ADMET Predictor was already leveraging these technologies to help our clients design and optimize new compounds. By tightly integrating mechanistic simulation with AI/ML and wrapping it in a powerful, customizable software platform that can be seamlessly deployed into existing workflows, we are now making predictions more accurate and easier to access for our clients around the world." Learn more about ADMET Predictor 13 or request a demo. About Simulations Plus, Inc. With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at Follow us on LinkedIn | X | YouTube. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2024 ESG update. Forward-Looking Statements Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like "believe," "will", "can", "believe", "expect," "anticipate" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) mean that these are our best estimates as of this writing, but there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Forward looking statements contained in this press release include, but are not limited to, statements about expectations for the second half of 2025 and anticipated projections for fiscal year 2025. Factors that could cause or contribute to such differences include, but are not limited to: our ability to integrate our ALI and MC business units, our ability to meet our stated guidance, our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, market conditions, macroeconomic factors, and a sustainable market. Further information on our risk factors is contained in our quarterly, annual and current reports and filed with the U.S. Securities and Exchange Commission. View source version on Contacts Financial Profiles Lisa Fortuna310-622-8251slp@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Sarah Harkcom, General Counsel at Scientist.com, Wins European Legal Innovation & Technology 'Innovation Trailblazer' Award
Sarah Harkcom, General Counsel at Scientist.com, Wins European Legal Innovation & Technology 'Innovation Trailblazer' Award

Business Wire

time31 minutes ago

  • Business Wire

Sarah Harkcom, General Counsel at Scientist.com, Wins European Legal Innovation & Technology 'Innovation Trailblazer' Award

SAN DIEGO--(BUSINESS WIRE)-- the leading R&D procurement-orchestration platform for the life sciences, today announced that its General Counsel, Sarah Harkcom, has been named Innovation Trailblazer at the 2025 European Legal Innovation & Technology Awards. legal framework has supported more than $2.5 billion in outsourced research, enabling scientists to launch critical experiments in days rather than weeks or months. Share Harkcom was recognized for architecting a unified, cross-border contracting model now adopted by many of the world's top pharmaceutical companies and contract research organizations (CROs). The framework has already supported more than $2.5 billion in outsourced research, enabling scientists to launch critical experiments in days rather than weeks or months. 'Sarah's vision reshaped how the pharma industry does business,' said Kevin Lustig, PhD, CEO and Founder of 'Her streamlined legal model removes friction for both buyers and suppliers, giving researchers faster access to the services they need to discover life-changing cures.' Key achievements Industry standardization: Created global template agreements that underlie most transactions. Accelerated R&D: Reduced contract-cycle times from months to days, a breakthrough that proved vital during the COVID-19 pandemic and continues to speed progress against other diseases. Global impact: The model's cross-jurisdictional design delivers uniform compliance and efficiency for partners in 80 countries. The awards ceremony took place on May 28 in Milan, Italy. For a full list of honorees, visit the European Legal Innovation & Technology Awards website. About makes it easy for life-science teams to find, vet and order the research services and products they need—often in days instead of weeks. Its online marketplace brings together 6,000+ pre-qualified suppliers across 1,000-plus research categories, all with built-in regulatory and data-privacy controls. The platform powers secure sourcing hubs for 20 of the world's top 30 pharmaceutical companies, 100+ biotech firms and the U.S. National Institutes of Health (NIH). Founded in 2007 and continually enhanced with AI tools, helps scientists spend less time on paperwork and more time on discovery. Learn more at

Germany's Merz set to press for lower tariffs in Trump meeting
Germany's Merz set to press for lower tariffs in Trump meeting

Yahoo

time35 minutes ago

  • Yahoo

Germany's Merz set to press for lower tariffs in Trump meeting

German Chancellor Friedrich Merz will today push for reduced American tariffs in his first meeting with US President Donald Trump in Washington, DC. Merz will also highlight his country's increased defense spending and press for stronger American support for Ukraine, hoping to leverage what has so far been a positive, if distant, relationship: The two former businessmen text each other and are on a first-name basis, Handelsblatt noted. The visit is crucial for Merz — Germany's huge manufacturing and carmaking sectors are particularly vulnerable to Trump's steel and auto tariffs — but he also has cards to play, The Wall Street Journal said, and is expected to argue that Washington needs Europe in order to present a unified front against China.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store